Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.51 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | IKBKB | O14920 | 3/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | CHUK | O15111 | 1/20 | 0.46 |
| ▸ | IKBKG | Q9Y6K9 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880255 | 0.99 | KDM4E (0.54) | KDM4ETDP1CA12CA1CA2 | |
| SCHEMBL31661936 | 0.87 | IKBKB (0.52) | CA12CA1CA2CA4CA5A | |
| SCHEMBL2880254 | 0.86 | IKBKB (0.42) | KDM4ETDP1CA12CA1CA2 | |
| SCHEMBL17799582 | 0.77 | CA12 (0.58) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15260648 | 0.77 | CYP19A1 (0.49) | CA1CA2CA9IKBKBCYP19A1 | |
| SCHEMBL28401036 | 0.76 | CYP19A1 (0.48) | CA1CA2CA9IKBKBCYP19A1 | |
| SCHEMBL29177680 | 0.76 | CYP19A1 (0.48) | CA1CA2CA9IKBKBCYP19A1 | |
| SCHEMBL29986368 | 0.76 | CYP19A1 (0.48) | IKBKBCYP19A1PLAUAPP | |
| SCHEMBL15025442 | 0.75 | CA1 (0.60) | CA12CA1CA2CA4CA5A | |
| SCHEMBL28537163 | 0.75 | IKBKB (0.40) | BCL2L1IKBKBCYP19A1CHUKIKBKG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111354879-A | Systems, structures and materials for electrochemical device thermal management | 全球网络视野有限责任公司 | 2020-06-30 | — | — | CN | disclosed |
| WO-2019046759-A1 | SOLVENT COATABLE OLED EMITTER COMPOSITION CONTAINING NON-PLASMONIC MOLECULAR NOBLE METAL NANOPARTICLES AND EMITTER MATERIALS IN NONCRYSTALLIZABLE MOLECULAR ORGANIC SEMICONDUCTORS | MOLECULAR GLASSES, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | DNM1, FIS1, DCUN1D1 | KDM4E 4672/4885TDP1 977/4885CA12 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.